LMR Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

LMR Partners’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-27,324	Closed	-$320K	–	595
2017 Q2	$320K	Buy	+27,324	New	+$339K	0.02%	462

Other funds holding MYOV

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

LMR Partners's MYOV Position: Q3 2017 in Review

LMR Partners sold out of Myovant Sciences Ltd. (MYOV) in Q3 2017, closing a stake of 27,324 shares — an estimated $320K sold.

LMR Partners first reported a position in MYOV in Q2 2017 and held it in 1 quarter. The position peaked at $320K in Q2 2017. 34 funds tracked by Wall St. Rank hold MYOV as of Q3 2017.

LMR Partners reported no remaining Myovant Sciences Ltd. position as of Q3 2017 after selling out during the quarter.
LMR Partners sold 27,324 Myovant Sciences Ltd. shares in Q3 2017, an estimated $320K.
LMR Partners first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 1 quarter.
LMR Partners's Myovant Sciences Ltd. position peaked at $320K in Q2 2017.
34 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.